Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 15 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

27%

4 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (8)
P 1 (1)
P 2 (1)
P 3 (3)
P 4 (1)

Trial Status

Recruiting9
Completed3
Not Yet Recruiting2
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 3 completed trials

Clinical Trials (15)

Showing 15 of 15 trials
NCT06911944Phase 4Not Yet RecruitingPrimary

Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

NCT07328165Not ApplicableActive Not RecruitingPrimary

The Impact of Core Stability Versus Respiratory Muscle Strengthening Exercises on Bone Mineral Density in Children With Down Syndrome

NCT07425769Not ApplicableRecruitingPrimary

Adapting RDAD for DS

NCT07534085Not ApplicableCompletedPrimary

Effects of a Structured Physical Activity Program on Balance and Functional Performance in Children With Down Syndrome

NCT07135167Phase 3RecruitingPrimary

Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome

NCT07213063Not ApplicableRecruitingPrimary

Effects of Chronic Creatine and Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Oxidative Stress, Inflammation, Muscle Strength, and Body Composition in Individuals With Down Syndrome

NCT07234695Phase 3Recruiting

LEvetiracetam to Prevent Seizures in Symptomatic Alzheimer's Disease in Adults With Down Syndrome

NCT07278492Phase 1Not Yet RecruitingPrimary

NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome

NCT07232134Phase 3Recruiting

The Efficacy of Therapy in Patients With Acute Myeloid Leukemia and Down Syndrome in Russia

NCT07163780Not ApplicableRecruitingPrimary

The Effect of the HEP Approach in Infants With Down Syndrome

NCT06993324CompletedPrimary

Awareness of Families With Down Syndrome Children About the Role of Physical Therapy in Egypt

NCT07101523Not ApplicableRecruiting

Using Technologies to Promote HEalthy Lifestyles in Adolescents With Intellectual Disabilities

NCT06851338Not ApplicableRecruiting

Pediatric Down Syndrome Post-Approval Study

NCT06748248Not ApplicableRecruitingPrimary

Suspension Therapy Effects on Mobility and Balance in Down Syndrome

NCT01699711Phase 2CompletedPrimary

Normalization of dyrk1A and APP Function as an Approach to Improve Cognitive Performance and Decelerate AD Progression in DS Subjects: Epigallocatechin Gallate as Therapeutic Tool

Showing all 15 trials

Research Network

Activity Timeline